Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Case report

Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma

Online download statistics by month:

Online download statistics by month: May 2020 to December 2022

	Abstract	Full	Pdf
May 2020	231	231	113
Jun 2020	110	110	69
Jul 2020	54	54	45
Aug 2020	38	39	30
Sep 2020	56	56	30
Oct 2020	43	43	21
Nov 2020	32	32	9
Dec 2020	39	39	15
Jan 2021	42	42	32
Feb 2021	47	47	23
Mar 2021	60	60	33
Apr 2021	58	58	25
May 2021	70	70	28
Jun 2021	40	40	22
Jul 2021	44	44	22
Aug 2021	33	33	17
Sep 2021	57	57	25
Oct 2021	40	40	26
Nov 2021	47	48	37
Dec 2021	34	34	12
Jan 2022	33	37	17
Feb 2022	22	22	13
Mar 2022	49	53	23
Apr 2022	63	65	22
May 2022	46	46	20
Jun 2022	48	51	36
Jul 2022	41	43	15
Aug 2022	56	59	20
Sep 2022	44	44	18
Oct 2022	44	46	22
Nov 2022	40	42	26
Dec 2022	24	24	12
Total	1685	1709	878